| Financial Year |
March 31 2023 |
| Monetary Funds |
7,079,310,784.49 |
| Held-for-trading Financial Assets |
100,162,057.38 |
| Notes Receivable |
1,842,901,641.50 |
| Accounts Receivable |
3,781,827,419.89 |
| Advances to Suppliers |
527,076,880.93 |
| Other Receivables |
503,800,221.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,365,696,631.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
663,562,184.54 |
| Total Current Assets |
19,422,468,808.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,581,561,196.02 |
| Long-term Equity Investment |
24,072,841.58 |
| Investment Properties |
7,744,398.74 |
| Fixed Assetes |
11,202,928,383.09 |
| Under-construction Projects |
6,820,890,716.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,478,443,647.65 |
| R&D expenses |
-- |
| Goodwill |
196,491,056.23 |
| Long-Term Deferred and Prepaid Expenses |
35,310,391.99 |
| Deferred Income Tax Assets |
171,336,083.75 |
| Other Non-Current Assets |
150,591,014.39 |
| Sub-Total of Non-Current Assets |
21,683,494,749.09 |
| Total Assets |
41,105,963,557.61 |
| Short-Term Loans |
12,988,645,042.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
403,144,344.87 |
| Accounts Payable |
2,128,437,954.31 |
| Accounts Received In Advance |
721,594.39 |
| Employee Compensation Payable |
24,800,360.08 |
| Taxes Payable |
168,593,210.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,010,108.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,605,916,963.21 |
| Other Current Liabilities |
48,102,619.86 |
| Sub-Total of Current Liabilities |
17,917,318,111.29 |
| Long-term Loans |
8,784,983,844.73 |
| Bonds Payable |
305,024,240.62 |
| Long-Term Accounts Payable |
836,255,338.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,287,811.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,098,217,716.74 |
| Total Liabilities |
29,015,535,828.03 |
| Paid-In Capital(Or Share Stock) |
1,576,127,767.00 |
| Capital Surplus |
3,158,597,880.72 |
| Surplus Reserve |
169,865,665.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,401,758,558.08 |
| Minority Stockholder's Interest |
1,730,596,013.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,359,831,716.10 |
| Owner's Equity（Stockholder's Equity） |
12,090,427,729.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,105,963,557.61 |
